News
Feed
Events
Feed
News
+ Events
Feed

Andera Partners

  • Country France

Latest News

26 July 2024

09:00 Corporate

Andera Partners

Corporate

Andera Partners Co-Leads $196 Million Round for Kestra Medical and Welcomes Raymond W. Cohen to Board of Directors

25 July 2024

10:00 Corporate

Andera Partners

Corporate

Andera Partners’ portfolio company JenaValve Technology acquired by Edwards Lifesciences

09:30 Corporate

Andera Partners

Corporate

Andera Partners’ portfolio company TRiCares secures $50 million in Series D Financing to Support Upcoming Clinical Milestones

15 July 2024

09:30 Corporate

Andera Partners

Corporate

Andera Partners’ portfolio company Amolyt Pharma completes acquisition by AstraZeneca

9 July 2024

08:10 Corporate

Andera Partners

Corporate

Andera Partners co-leads a €63 million Series A round for Munich-based autoimmune biotech SciRhom

14 March 2024

11:10 Corporate

Andera Partners

Corporate

Andera Partners’ portfolio company Tubulis closes upsized €128 Million Series B2 to accelerate the development of its ADC Pipeline

09:00 Corporate

Andera Partners

Corporate

Amolyt Pharma, an Andera Partners’ portfolio company, announces its sale to AstraZeneca

14 November 2023

07:15 Corporate

Andera Partners

Corporate

Andera Partners co-leads a €67.5 million ($72 million) oversubscribed Series C round for cancer immunotherapy company Nouscom

15 May 2023

09:00 Corporate

Andera Partners

Corporate

Andera Partners co-leads a €40 million Series A of Dualyx, a Belgian biotech developing novel Treg therapies for autoimmune diseases

10 May 2023

09:00 Corporate

Andera Partners

Corporate

Andera Partners appoints Stefan Keitel Senior Advisor DACH region further strengthening its presence in the German, Austrian and Swiss private equity markets

18 April 2023

09:15 Corporate

Andera Partners

Corporate

Andera Partners co-leads a Series A extension round totalling € 47.75 million for radiopharmaceutical company Ariceum Therapeutics

13 April 2023

12:45 Corporate

Andera Partners

Corporate

Andera Partners leads $48.5 Million Series A financing for medical device company BioVentrix®

15 March 2023

13:05 Corporate

Andera Partners

Corporate

Andera Partners co-leads $25m extension round for FIRE1, an Irish medtech developing breakthrough technology for patients with heart failure

16 February 2023

09:00 Corporate

Andera Partners

Corporate

Ahead of its business plan, Andera Partners approaches 4 billion euros in assets under management and announces a new 2028 target of 6 to 8 billion euros

14 February 2023

09:00 Corporate

Andera Partners

Corporate

Andera Partners Portfolio Company Mineralys Therapeutics Successfully Completes Upsized $192 Million Nasdaq IPO

26 January 2023

13:10 Corporate

Andera Partners

Corporate

Andera Partners Participates in the €45 Million Series B Financing of Grey Wolf Therapeutics, led by Pfizer Ventures, to Advance First-of-its-Kind Neoantigen Creation Approaches

10 January 2023

08:30 Corporate

Andera Partners

Corporate

Andera Partners invests in SoniVie, a medtech company developing a promising device for the treatment of hypertension

9 January 2023

14:00 Corporate

Andera Partners

Corporate

Andera Partners participates in the $138 Million Series C Financing of Amolyt Pharma led by Sofinnova Partners and co-led by Intermediate Capital Group

10 October 2022

10:00 Corporate

Andera Partners

Corporate

Andera Partners raises its largest life sciences fund at €456M, demonstrating the attractiveness of its activity and of the sector

7 July 2022

10:15 Corporate

Andera Partners

Corporate

Andera Partners strengthens its Life Sciences team with a new partner

8 June 2022

14:05 Corporate

Andera Partners

Corporate

Andera Partners co-leads $118 Million Oversubscribed Series B Financing of Mineralys Therapeutics to Advance the Development of Novel, Targeted Treatment for Hypertension

3 May 2022

11:05 Corporate

Andera Partners

Corporate

Andera Partners supports Tubulis in a €60 million Series B financing to accelerate the development of its ADCs

7 April 2022

12:59 Corporate

Andera Partners

Corporate

Andera Partners to sell its Life Sciences’ portfolio company ReViral to Pfizer

22 February 2022

09:30 Corporate

Andera Partners

Corporate

Andera Partners supports TargED Biopharmaceuticals in €39 million Series A financing to bring groundbreaking thrombolytic treatment to patients

2 August 2021

14:05 Corporate

Andera Partners

Corporate

Andera Partners’ Portfolio Company T-knife Announces $110 Million Series B Financing to Advance Pipeline of T-cell Receptor Therapies

27 April 2021

10:00 Corporate

Andera Partners

Corporate

Andera Partners strengthens its presence in the DACH region

Upcoming Events

No Events found